|
|
|
|
|
Detail |
| hsa-miR-29c |
|
Causal |
Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. |
2007 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
MicroRNAs play an essential role in the development of cardiac hypertrophy. |
2008 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
The role of microRNA genes in papillary thyroid carcinoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. |
2007 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. |
2005 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? |
2007 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Causal |
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. |
2007 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. |
2009 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. |
2009 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
Karyotype specific microRNA signature in chronic lymphocytic leukemia. |
2009 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD |
2009 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
MicroRNA expression and identification of putative miRNA targets in ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. |
2008 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Causal |
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. |
2008 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. |
2008 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Causal |
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
MicroRNA alterations in head and neck squamous cell carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
MicroRNA-regulated pathways associated with endometriosis. |
2009 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
MicroRNA-29c and microRNA-223 downregulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. |
2009 |
|
|
|
|
|
|
| hsa-miR-29c |
|
Unspecified |
Up-regulation of microRNA in bladder tumor tissue is not common. |
2009 |
|
|
|
|
|
|